TUMOR-SUPPRESSOR P53 IS A DIRECT TRANSCRIPTIONAL ACTIVATOR OF THE HUMAN BAX GENE

被引:72
|
作者
MIYASHITA, T [1 ]
REED, JC [1 ]
机构
[1] LA JOLLA CANC RES FDN, LA JOLLA, CA 92037 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bax gene promoter region contains four motifs with homology to consensus p53-binding sites. In cotransfection assays using p53-deficient tumor cell lines, wild-type but not mutant p53 expression plasmids transactivated a reporter gene plasmid that utilized the bax gene promoter to drive transcription of chloramphenicol acetyltransferase. In addition, wildtype p53 transactivated reporter gene constructs containing a heterologous minimal promoter and a 39-bp region from the bax gene promoter in which the p53-binding site consensus sequences reside. Introduction of mutations into the consensus p53-binding site sequences abolished p53 responsiveness of reporter gene plasmids. Wild-type but not mutant p53 protein bound to oligonucleotides corresponding to this region of the bax promoter, based on gel retardation assays. Taken together, the results suggest that bax is a p53 primary-response gene, presumably involved in a p53-regulated pathway for induction of apoptosis.
引用
收藏
页码:293 / 299
页数:7
相关论文
共 50 条
  • [31] OVEREXPRESSION OF THE TUMOR-SUPPRESSOR GENE P53 IS NOT IMPLICATED IN NEUROENDOCRINE TUMOR CARCINOGENESIS
    WANG, DG
    JOHNSTON, CF
    ANDERSON, N
    SLOAN, JM
    BUCHANAN, KD
    JOURNAL OF PATHOLOGY, 1995, 175 (04): : 397 - 401
  • [32] DIFFERENTIAL REGULATION OF PLASMINOGEN-ACTIVATOR AND INHIBITOR GENE-TRANSCRIPTION BY THE TUMOR-SUPPRESSOR P53
    KUNZ, C
    PEBLER, S
    OTTE, J
    VONDERAHE, D
    NUCLEIC ACIDS RESEARCH, 1995, 23 (18) : 3710 - 3717
  • [33] CYCLIN-G IS A TRANSCRIPTIONAL TARGET OF THE P53 TUMOR-SUPPRESSOR PROTEIN
    OKAMOTO, K
    BEACH, D
    EMBO JOURNAL, 1994, 13 (20): : 4816 - 4822
  • [34] GERMLINE MUTATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CHILDREN WITH OSTEOSARCOMA
    MCINTYRE, JF
    SMITHSORENSEN, B
    FRIEND, SH
    KASSELL, J
    BORRESEN, AL
    YAN, YX
    RUSSO, C
    SATO, J
    BARBIER, N
    MISER, J
    MALKIN, D
    GEBHARDT, MC
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) : 925 - 930
  • [35] MUTATIONS IN TUMOR-SUPPRESSOR GENE P53 IN 2 FELINE FIBROSARCOMAS
    MAYR, B
    SCHAFFNER, G
    KURZBAUER, R
    SCHNEIDER, A
    REIFINGER, M
    LOUPAL, G
    BRITISH VETERINARY JOURNAL, 1995, 151 (06): : 707 - 713
  • [36] THE P53 TUMOR-SUPPRESSOR GENE IN THE PATHOGENESIS OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE
    ODOWD, JF
    DUNNE, B
    WILLCOCKS, TC
    PARFREY, NA
    LABORATORY INVESTIGATION, 1994, 70 (01) : A117 - A117
  • [37] DNA-DAMAGE, ONCOGENESIS AND THE P53 TUMOR-SUPPRESSOR GENE
    LEE, JM
    ABRAHAMSON, JLA
    BERNSTEIN, A
    MUTATION RESEARCH, 1994, 307 (02): : 573 - 581
  • [38] MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IS NOT A FEATURE OF ENDOMETRIAL HYPERPLASIAS
    KOHLER, MF
    NISHII, H
    HUMPHREY, PA
    SASKI, H
    MARKS, J
    BAST, RC
    CLARKEPEARSON, DL
    BOYD, J
    BERCHUCK, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (03) : 690 - 694
  • [39] Transcriptional and epigenetic regulation of the p53 tumor suppressor gene
    Saldana-Meyer, Ricardo
    Recillas-Targa, Felix
    EPIGENETICS, 2011, 6 (09) : 1068 - 1077
  • [40] THE P53 TUMOR-SUPPRESSOR GENE FREQUENTLY IS ALTERED IN GYNECOLOGIC CANCERS
    BERCHUCK, A
    KOHLER, MF
    MARKS, JR
    WISEMAN, R
    BOYD, J
    BAST, RC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (01) : 246 - 252